APPENDIX 3
Witnesses
The following witnesses gave evidence. Those marked
· gave oral evidence. Those marked E participated in the
Seminar at Imperial College on 24 January (see Appendix 4). Those
marked v were involved in a visit to Hinxton Genome Campus on
31 January (see Appendix 5). The mark indicates that the
evidence is not printed but is available for inspection at the
House of Lords Record Office (telephone 0207 219 5316).
· Academy of Medical Sciences (represented
in oral evidence by Professor John Bell)
Acute Coronary Event DNA Library
(ADLIB) Project
Association of Chief Police Officers
(Crime Committee)
Association of Chief Police Officers
in Scotland
· AstraZeneca (represented in
oral evidence by Dr Kevin Cheeseman)
Avon Longitudinal Study of Parents and
Children
E Dr Paul Aylin, Imperial College,
London
· Professor John Bell, University
of Oxford (in his oral evidence, representing the Academy of Medical
Sciences)
Biotechnology and Biological Sciences
Research Council
v Professor Martin Bobrow, Cambridge
University
v Professor Allan Bradley, Director
of the Sanger Centre
British Embassy, Tokyo (Science and
Technology Section)
British Embassy, Washington (Science
and Technology Section)
British Embassy, Paris (Science and
Technology Section)
British Heart Foundation
v Dr Graham Cameron and Professor
Michael Ashburner (Joint Heads of the European Bioinformatics
Institute, although their written evidence was submitted on a
personal basis)
Cancer Research Campaign
· Professor Ruth Chadwick, Lancaster
University
Child Support Agency
· Department of Health (represented
in oral evidence by Professor Sir John Pattison, Mr Philip Walker
and Dr Peter Drury)
European Agency for the Evaluation
of Medicinal Products
· Forensic Science Service (represented
in oral evidence by Dr Bob Bramley and Dr David Werrett)
E Dr John Fox, Director of Statistics,
Department of Health
E Professor David Forman, University
of Leeds
· General Medical Council (represented
in oral evidence by Professor Hilary Thomas, University of Surrey,
and Ms Jane O'Brien)
GenEthics News
· GlaxoSmithKline - formerly
Glaxo Wellcome and SmithKline Beecham (represented in oral evidence
by Dr Allen Roses)
E Professor Carole Goble, University
of Manchester
E Dr Peter Goldblatt, Chief Medical
Statistician, Office for National Statistics
· Home Office Policing and Crime
Reduction Group (represented in oral evidence by Dr Jill Tan)
Human Fertilisation & Embryology
Authority
Imperial Cancer Research Fund
E Dr Lars Järup, Imperial College,
London
Mr R A C Ker and Mr J Storry
Laboratory of the Government Chemist
and University Diagnostics Ltd
Lilly UK
Dr Paul Martin
· Medical Research Council (represented
in oral evidence by Professor Sir George Radda and Dr Frances
Rawle)
Nuffield Council on Bioethics
· Baroness O'Neill of Bengarve
Office of the Data Protection Commissioner
Parliamentary Office of Science and
Technology
E Professor Jørgen Olsen, Danish
Institute of Cancer Epidemiology
Oxagen Ltd
· Pfizer (represented in oral
evidence by Dr Aidan Power)
Public Health Genetics Network Executive
Group
E Professor Ian Purves, University
of Newcastle
Roche Products Ltd
Royal College of Obstetricians and
Gynaecologists
Royal Society of Edinburgh
Sanger Centre
Scottish Executive Health Department
E Dr Mary Smalls, Information and
Statistics Division, Scottish Health Service
v Sir John Sulston, Founder Director
of the Sanger Centre
UK Neonatal
Screening Laboratories Network
· The Wellcome Trust (represented
in oral evidence by Dr T Michael Dexter and Dr Alan Doyle)
|